BSE filing, NSE: VERTEX. Summary written from the filing by ALFA Finder's alert engine.
Vertex Securities Ltd: key numbers
- Share price
- ₹2.80
- Market cap
- ₹25.90 Cr
- Revenue (annual)
- ₹6.90 Cr
- Net profit (annual)
- ₹-2.37 Cr
- P/E (TTM)
- -9.8×Sector 19.7×
- Promoter holding
- 36.43%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vertex Securities Ltd
All →Vertex Securities Q2 FY27 Results: Net Loss of ₹0.5 Cr, Loss Widens
Vertex Securities Ltd reported revenue from operations of ₹1.7 Cr (-10.5% YoY) and a net loss of ₹0.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.5 Cr
Vertex Securities Other Announcement
Vertex Securities Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine regulatory compliance disclosure.
Vertex Securities Annual General Meeting
Vertex Securities held its 33rd Annual General Meeting on September 29, 2026, transacting ordinary and special business, including financial statement adoption and related party transaction approvals.
Vertex Securities Annual Report
Vertex Securities Limited filed its Annual Report for the financial year 2025-26. The document also includes the notice for the 33rd Annual General Meeting.
Vertex Securities Annual General Meeting
Vertex Securities Limited issued notice for its 33rd Annual General Meeting scheduled on September 29, 2026. The meeting will be held via video conferencing.
Vertex Securities Management Change
Vertex Securities Ltd announced the cessation of Meera Haridas as Chief Financial Officer effective July 31, 2026, due to her superannuation.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.